Walgreens Boots Alliance (NASDAQ:WBA) had its price objective hoisted by SunTrust Banks to $75.00 in a research note released on Friday, The Fly reports. SunTrust Banks currently has a hold rating on the pharmacy operator’s stock. SunTrust Banks also issued estimates for Walgreens Boots Alliance’s Q1 2019 earnings at $1.49 EPS, Q2 2019 earnings at $1.73 EPS, Q3 2019 earnings at $1.68 EPS, FY2019 earnings at $6.50 EPS and FY2020 earnings at $7.00 EPS.

WBA has been the subject of a number of other reports. Loop Capital raised their price target on Walgreens Boots Alliance to $80.00 and gave the stock a buy rating in a research note on Friday, June 29th. Pivotal Research lowered their price objective on Walgreens Boots Alliance from $70.00 to $60.00 and set a hold rating for the company in a research report on Monday, July 2nd. Mizuho cut Walgreens Boots Alliance from a buy rating to a neutral rating and set a $64.00 price target on the stock. in a research note on Monday, July 2nd. BidaskClub upgraded Walgreens Boots Alliance from a strong sell rating to a sell rating in a research note on Saturday, June 16th. Finally, TheStreet upgraded Walgreens Boots Alliance from a c+ rating to a b rating in a research note on Wednesday, September 12th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $77.56.

Shares of Walgreens Boots Alliance stock traded up $2.60 on Friday, reaching $73.50. The company had a trading volume of 9,645,179 shares, compared to its average volume of 6,227,956. The stock has a market cap of $72.35 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 1.11 and a beta of 1.04. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93. Walgreens Boots Alliance has a 1 year low of $59.07 and a 1 year high of $80.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. Sell-side analysts predict that Walgreens Boots Alliance will post 5.98 earnings per share for the current fiscal year.

In related news, COO Ornella Barra acquired 1,700,000 shares of Walgreens Boots Alliance stock in a transaction dated Monday, July 16th. The shares were acquired at an average cost of $65.15 per share, for a total transaction of $110,755,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the completion of the sale, the director now owns 10,943 shares in the company, valued at $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.

A number of institutional investors have recently bought and sold shares of the business. Livingston Group Asset Management CO operating as Southport Capital Management acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $154,000. Bank of Montreal Can raised its stake in Walgreens Boots Alliance by 17.5% in the third quarter. Bank of Montreal Can now owns 1,941,036 shares of the pharmacy operator’s stock valued at $141,502,000 after buying an additional 288,921 shares in the last quarter. Busey Trust CO raised its stake in Walgreens Boots Alliance by 8.1% in the third quarter. Busey Trust CO now owns 10,824 shares of the pharmacy operator’s stock valued at $789,000 after buying an additional 812 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in Walgreens Boots Alliance by 10.1% in the third quarter. Parkside Financial Bank & Trust now owns 7,649 shares of the pharmacy operator’s stock valued at $557,000 after buying an additional 703 shares in the last quarter. Finally, Pittenger & Anderson Inc. raised its stake in Walgreens Boots Alliance by 82.9% in the third quarter. Pittenger & Anderson Inc. now owns 27,280 shares of the pharmacy operator’s stock valued at $1,989,000 after buying an additional 12,365 shares in the last quarter. Institutional investors own 61.92% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Recommended Story: Intrinsic Value

The Fly

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.